Expression of megakaryocytic and erythroid properties in human leukemic cells
- PMID: 8641337
Expression of megakaryocytic and erythroid properties in human leukemic cells
Abstract
Previous studies have suggested that megakaryocytes and erythrocytes may share a common precursor cell. However, studies on the commitment to erythroid and megakaryocytic lineages have been hampered by the lack of suitable human leukemic cell lines having this kind of bipotential differentiation capability. We investigated the coexpression of megakaryocytic and erythroid markers in human leukemic cell lines as well as the capability of these cells to further differentiate upon exposure to differentiation-inducing agents. We report that the JK-1 cell line, previously characterized as a typically erythroid cell line with spontaneous differentiation to red cells, actually coexpressed megakaryocytic cell surface antigens and erythroid spectrins. We also report that the JK-1 cells could be induced to differentiate along the megakaryocytic lineage by treatment with 12-O-tetradecanoyl-phorbol-13-acetate (TPA). The other cell lines studied variably expressed megakaryocytic and erythroid antigens, the DAMI and CMK cells predominantly megakaryocytic properties and the T-33 and K562 cells some erythroid markers, whereas the HEL cells expressed markers for both lineages of differentiation. Our results suggest that the JK-1 cell line represents an immature cell population that has not yet been committed to either of the two lineages of differentiation. The JK-1 cell line might provide a useful tool for further studies on the transcriptional regulation of erythroid and megakaryocytic phenotypes and for studies on the commitment to these lineages of differentiation. Our results also suggest that the leukemic cell lines show a considerable plasticity in the expression of properties normally specific for distinct lineages of differentiation.
Similar articles
-
Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.Leukemia. 1995 Feb;9(2):341-9. Leukemia. 1995. PMID: 7869773
-
Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages.J Biol Response Mod. 1986 Jun;5(3):250-62. J Biol Response Mod. 1986. PMID: 2425057
-
Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.Int J Cell Cloning. 1992 Jul;10(4):232-40. doi: 10.1002/stem.5530100406. Int J Cell Cloning. 1992. PMID: 1645031
-
Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia.Leuk Res. 2004 Dec;28(12):1243-51. doi: 10.1016/j.leukres.2004.03.022. Leuk Res. 2004. PMID: 15475063 Review.
-
Leukemic cell maturation.Arch Pathol Lab Med. 1985 Apr;109(4):309-13. Arch Pathol Lab Med. 1985. PMID: 3885897 Review.
Cited by
-
Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.J Virol. 2006 Apr;80(8):4026-37. doi: 10.1128/JVI.80.8.4026-4037.2006. J Virol. 2006. PMID: 16571819 Free PMC article.
-
Cis-vaccenic acid induces differentiation and up-regulates gamma globin synthesis in K562, JK1 and transgenic mice erythroid progenitor stem cells.Eur J Pharmacol. 2016 Apr 5;776:9-18. doi: 10.1016/j.ejphar.2016.02.041. Epub 2016 Feb 12. Eur J Pharmacol. 2016. PMID: 26879870 Free PMC article.
-
PR-Set7 establishes a repressive trans-tail histone code that regulates differentiation.Mol Cell Biol. 2008 Jul;28(14):4459-68. doi: 10.1128/MCB.00410-08. Epub 2008 May 12. Mol Cell Biol. 2008. PMID: 18474616 Free PMC article.
-
Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.Blood. 2008 Apr 1;111(7):3553-61. doi: 10.1182/blood-2007-05-088161. Epub 2008 Jan 7. Blood. 2008. PMID: 18180380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous